Evaluation of serotypes of Streptococcus pneumoniae isolated from otitis media patients by multiplex polymerase chain reaction

ORL

Volumn 68, Issue 3, 2006, Pages 135-138

  Billal, Dewan S ^a   Hotomi, Muneki ^a   Tasnim, Sayeeda ^a   Fujihara, Keiji ^a   Yamanaka, Noboru ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Acute otitis media; Polymerase chain reaction; Serogroup; Serotype; Streptococcus pneumoniae

Indexed keywords

ANTIBIOTIC AGENT; PNEUMOCOCCUS VACCINE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; HUMAN; MIDDLE EAR; MULTIPLEX POLYMERASE CHAIN REACTION; NASOPHARYNX; NONHUMAN; OTITIS MEDIA; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

BACTERIAL CAPSULES; CHILD; FEMALE; HUMANS; MALE; NASOPHARYNX; OTITIS MEDIA; PNEUMOCOCCAL INFECTIONS; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

EID: 33646092069     PISSN: 03011569     EISSN: None     Source Type: Journal    
DOI: 10.1159/000091275     Document Type: Article

References (22)

1. Bluestone CD, Stephenson JS, Martin LM: Ten-year review of otitis media pathogens. Pediatr Infect Dis J 1992;11(suppl 8):7-11.
2. Jacobs MR: Antibiotic-resistant Streptococcus pneumoniae in acute otitis media: overview and update. Pediatr Infect Dis J 1998;17:947-952.
3. Dagan R, Leibovitz E, Leiberman A, Yagupsky P: Clinical significance of antibiotic resistance in acute otitis media and implication of antibiotic treatment on carriage and spread of resistant organisms. Pediatr Infect Dis J 2000;19(suppl 5):S57-S65.
4. Jacobs MR: Increasing antibiotic resistance among otitis media pathogens and their susceptibility to oral agents based on pharmacodynamic parameters. Pediatr Infect Dis J 2000;19(suppl 5):S47-S55.
5. Haddad J Jr, Saiman L, San Gabriel P, Chin NX, Whittier S, Deeter RG, Takoudes TG, Keller JL, Della-Latta P: Nonsusceptible Streptococcus pneumoniae in children with chronic otitis media with effusion and recurrent otitis media undergoing ventilating tube placement. Pediatr Infect Dis J 2000;19:432-437.
6. Alonso De Velasco E, Verheal AF, Verhoef J, Snippe H: Streptococcus pneumoniae: virulence factors, pathogenesis, and vaccines. Microbiol Rev 1995;59:591-603.
7. Veenhoven R, Bogaert D, Uiterwaal C, Brouwer C, Kiezebrink H, Bruin J, Ijzerman E, Hermans P, de Groot R, Zegers B, Kuis W, Rijkers G, Schilder A, Sanders E: Effect of conjugate pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media: a randomised study. Lancet 2003;361:2189-2195.
8. Whitney CG, Farley MM, Hadler J, Harrison LH, Bennett NM, Lynfield R, Reingold A, Cieslak PR, Pilishvili T, Jackson D, Facklam RR, Jorgensen JH, Schuchat A: Active Bacterial Core Surveillance of the Emerging Infections Program Network: Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 2003;348:1737-1746.
9. Avery OT, MacLeod CM, McCarty M: Studies on the chemical nature of the substance inducing transformation of pneumococcal types: induction of transformation by a desoxyribonucleic acid fraction isolated from a Pneumococcus type III. Mol Med 1995;1:344-365.
10. Porat N, Arguedas A, Spratt BG, Trefler R, Brilla E, Loaiza C, Godoy D, Bilek N, Dagan R: Emergence of penicillin-nonsusceptible Streptococcus pneumoniae clones expressing serotypes not present in the antipneumococcal conjugate vaccine. J Infect Dis 2004;190:2154-2161.
11. Spratt BG, Greenwood BM: Prevention of pneumococcal disease by vaccination: does serotype replacement matter? Lancet 2000;356:1210-1211.
12. Scott JA, Hall AJ, Dagan R, Dixon JM, Eykyn SJ, Fenoll A, Hortal M, Jette LP, Jorgensen JH, Lamothe F, Latorre C, Macfarlane JT, Shakes DM, Smart LE, Taunay A: Serogroup-specific epidemiology of Streptococcus pneumoniae: association with age, sex, and geography in 7,000 episodes of invasive disease. Clin Infect Dis 1999;22:973-981.
13. Lawrence ER, Griffiths DB, Martin SA, George RC, Hall LMC: Evaluation of semiautomated multiplex PCR assay for determination of Streptococcus pneumoniae serotypes and serogroups. J Clin Microbiol 2003;41:601-607.
14. Brito DA, Ramirez M, de Lencastre H: Serotyping Streptococcus pneumoniae by multiplex PCR. J Clin Micribiol 2003;41:2378-2384.
15. Saha SK, Baqui AH, Darmstadt GL, Ruhulamin M, Hanif M, Arifeen SEI, Santosham M, Oishi K, Nagatake T, Black RE: Comparison of antibiotic resistance and serotype composition of carriage and invasive pneumococci among Bangladeshi children: implication of treatment policy and vaccine formulation. J Clin Microbiol 2003;41:5582-5587.
16. Henrichsen J: Six newly recognized types of Streptococcus pneumoniae. J Clin Microbiol 1995;33:2759-2762.
17. Johnson CE, Carlin SA, Super DM, Rehmus JM, Roberts DG, Christopher NC, Whitwell JK, Shurin PA: Cefixime compared with amoxicillin for treatment of acute otitis media. J Pediatr 1991;119:117-122.
18. Luotonen J, Herva E, Karma P, Timonen M, Leinonen M, Makela PH: The bacteriology of acute otitis media in children with special reference to Streptococcus pneumoniae as studied by bacteriological and antigen detection methods. Scand J Infect Dis 1981;13:177-183.
19. Block SL: Causative pathogens, antibiotic resistance and therapeutic considerations in acute otitis media. Pediatr Infect Dis J 1997;16:449-456.
20. Lo WT, Wang CC, Yu CM, Chu ML: Rate of nasopharyngeal carriage, antimicrobial resistance and serotype of Streptococcus pneumoniae among children in northern Taiwan. J Microbiol Immunol Infect 2003;36:175-181.
21. Eskola J, Kilpi T, Palmu A, Jokinen J, Haapakoski J, Herva E, Takala A, Kayhty H, Karma P, Kohberger R, Siber G, Makela PH, Finnish Otitis Media Study Group: Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med 2001;344:403-409.
22. Hanage WP, Auranen K, Syrjänen R, Herva E, Mäkelä PH, Kilpi T, Spratt BG: Ability of pneumococcal serotypes and clones to cause acute otitis media: implications for the prevention of otitis media by conjugate vaccines. Infect Immun 2004;72:76-81.